Clinical trials
Observational COVID-19 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 30 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Unknown status | 7 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| I.M. Sechenov First Moscow State Medical University | 5 |
| Eurasian Association of Therapists | 4 |
| Pirogov Russian National Research Medical University | 3 |
| Efferon JSC | 2 |
| Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" | 2 |
| National Research Center for Hematology, Russia | 2 |
| Saint Petersburg State University, Russia | 2 |
| Tomsk National Research Medical Center of the Russian Academy of Sciences | 2 |
| Avexima Diol LLC | 1 |
| Biosurf LLC. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 44 |
| Cardiovascular Diseases | 4 |
| Coronavirus Infections | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Atrial Fibrillation | 3 |
| Diabetes Mellitus | 3 |
| Hypertension | 2 |
| Ischemic Stroke | 2 |
| Myocardial Infarction | 2 |
| Myocardial Ischemia | 2 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.